Bitcoin price fell below $77,000, dropping to as low as $76,704 on Binance, as traders reduced risk ahead of a key U.S. Senate vote on the Digital Asset Market Clarity Act. Technical indicators show weakening short-term momentum with the 4-hour RSI below neutral and Bitcoin trading below the middle Bollinger Band, signaling seller control. The $75,500–$76,000 range is identified as critical short-term support, while resistance clusters near $78,400 and $80,000 could limit recovery. The Senate vote's outcome is crucial as failure to advance the bill may delay clearer crypto regulations in the U.S., adding to market uncertainty alongside macroeconomic risks like inflation and Federal Reserve policy. A break above $78,600 could improve Bitcoin's outlook, but a sustained drop below $75,500 risks further decline toward $72,800.
Bitcoin price faces a critical test near $75,500, with Pluang data showing a broad market decline as 36 of 50 major cryptocurrencies fell by September 15, 2026, 19:26 WIB. Among these, SXP dropped sharply by 46.27% to Rp37, contrasting with BAL's 11.14% rise to Rp16,297, while FIL fell 13.09% to Rp15,516 amid a 67% sell order activity. This snapshot highlights varied market momentum across digital assets on Pluang.
Monteverde & Associates PC is investigating the fairness of proposed mergers involving Synaptics (SYNA), Eagle Financial Services (EFSI), Victory Capital Holdings (VCTR), and Centerspace (CSR). Shareholders are urged to consider if the deals are fair...
At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...
Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...
Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...
Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...
